Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-15T23:41:27.460Z Has data issue: false hasContentIssue false

EPA-1016 - Comparative Analysis of Some Inflammation Mediators in Alzheimer's Disease and Schizophrenia in Aged

Published online by Cambridge University Press:  15 April 2020

L. Androsova
Affiliation:
Laboratory of Molecular Biochemistry, Mental Health Research Center of RAMS, Moscow, Russia
N. Mikhaylova
Affiliation:
Laboratory of Molecular Biochemistry, Mental Health Research Center of RAMS, Moscow, Russia
S. Zozulya
Affiliation:
Laboratory of Molecular Biochemistry, Mental Health Research Center of RAMS, Moscow, Russia
T. Kliushnik
Affiliation:
Laboratory of Molecular Biochemistry, Mental Health Research Center of RAMS, Moscow, Russia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Research of the last decade established that inflammatory reactions are involved in the pathogenesis of Alzheimer's disease (AD) and schizophrenia (Sch).

The aim of this paper to carry out a comparative analysis of some inflammation mediators [activity of leukocyte elastase (LE) and alpha 1- proteinase inhibitor (α1-PI), the level of CRP, IL-6 and IL-10] in the blood serum in patients with AD and in old aged patients with schizophrenia in comparison with healthy control of the same age.

There were a significant increase in activity of α1-PI, level of CRP, IL-6 and IL-10 (p<0.0001, p<0.05, p<0.01, p<0.01, respectively) and significant decrease of LE activity (p<0.0001) in the group of patients with AD compared to control. The activity of LE was positive correlated with MMSE scores (r =0.34, ?=0.0487) and the IL-6 level was negative correlated with MMSE scores (r =-0.46, ?=0.0077), ie cognitive decline was associated with decreased activity of LE and increased levels of IL-6. The group of patients with Sch was characterized only by a significant increase in activity α1-PI and level of CRP compared to control (p<0.0001, p<0.01, respectively). LE activity and IL-6 level in patients with AD significantly differ from patients with schizophrenia (p<0.05, p<0.01, respectively).

Thus, the low activity LE and high levels of IL-6 are observed only for patients with AD, but not for patients with schizophrenia. These parameters may serve as biological markers of the severity of AD.

Type
E03 - e-Poster Oral Session 03: Addiction and Geriatric Psychiatry
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.